[1] Chen C, Li M, Yang H, et al. Roles of thymosins in cancers and other organ systems[J]. World J Surg, 2005, 29(3):264-270. [2] Erickson-Viitanen S, Ruggieri S, Natalini P, et al. Thymosin beta 10, a new analog of thymosin beta 4 in mammalian tissues[J]. Arch Biochem Biophys, 1983, 225(2):407-413. [3] Wang H, Jian, S, Zhang Y, et al. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy[J]. World J Surg Oncol, 2014, 12:266. [4] Gu Y, Wang C, Wang Y, et al. Expression of thymosin beta10 and its role in non-small cell lung cancer[J]. Hum Pathol, 2009, 40(1):117-124. [5] Oien KA, Vass JK, Downie I, et al. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach[J]. Oncogene, 2003, 22(27):4287-4300. [6] Huang L, Zheng M, Zhou Q, et al. Identification of a gene-expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma[J]. Cancer, 2011, 117(15):3363-3373. [7] Alldinger I, Dittert D, Peiper M, et al. Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer[J]. Pancreatology, 2005, 5(4-5):370-379. [8] Lin SC, Morrison-Bogorad M. Developmental expression of mRNAs encoding thymosins beta 4 and beta 10 in rat brain and other tissues[J]. J Mol Neurosci, 1990, 2(1):35-44. [9] Nakanishi F, Ohkawa K, Ishida H, et al. Alteration in gene expression profile by full-length hepatitis B virus genome[J]. Intervirology, 2005, 48(2-3):77-83. [10] Ka SM, Rifai A, Chen JH, et al. Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease[J]. Nephrol Dial Transplant, 2006, 21(2):288-298. [11] Tsuji M, Monkawa T, Yoshino J, et al. Microarray analysis of a reversible model and an irreversible model of anti-Thy-1 nephritis[J]. Kidney Int, 2006, 69(6):996-1004. [12] Gutierrez-Pabello JA, McMurray DN, Adams LG. Upregulation of thymosin beta-10 by Mycobacterium bovis infection of bovine macrophages is associated with apoptosis[J]. Infect Immun, 2002, 70(4):2121-2127. [13] Lin SC, Morrison-Bogorad M. Cloning and characterization of a testis-specific thymosin beta 10 cDNAexpression in post-meiotic male germ cells[J]. J Biol Chem, 1991, 266(34):23347-23353. [14] Maelan AE, Rasmussen TK, Larsson LI. Localization of thymosin beta10 in breast cancer cells:relationship to actin cytoskeletal remodeling and cell motility[J]. Histochem Cell Biol, 2007, 127(1):109-113. [15] Mu H, Ohashi R, Yang H, et al. Thymosin beta10 inhibits cell mig-ration and capillary-like tube formation of human coronary artery endothelial cells[J]. Cell Motil Cytoskeleton, 2006, 63(4):222-230. [16] Hall AK. Thymosin beta-10 accelerates apoptosis[J]. Cell Mol Biol Res, 1995, 41(3):167-180. [17] Eadie JS, Kim SW, Allen PG, et al. C-terminal variations in beta-thymosin family members specify functional differences in actin-binding properties[J]. J Cell Biochem, 2000, 77(2):277-287. [18] Santelli G, Califano D, Chiappetta G, et al. Advances in thymosin beta10 research:differential expression, molecular mechanisms, and clinical implications in cancer and other conditions[J]. Cancer Invest, 2009, 27(10):1016-1022. [19] Xue B, Aguda AH, Robinson RC. Models of the actin-bound forms of the beta-thymosins[J]. Ann N Y Acad Sci, 2007, 1112(1):56-66. [20] Lee SH, Zhang W, Choi JJ, et al. Overexpression of the thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis[J]. Oncogene, 2001, 20(46):6700-6706. |